🔴 Nearly 600,000 Bottles of a Common Blood Pressure Drug Recalled Over Cancer-Causing Contamination 😲

A major drug safety alert has been issued after health authorities confirmed that hundreds of thousands of bottles of a commonly prescribed blood pressure medication were recalled due to concerns about a possible cancer-causing impurity.

The recall has raised concerns among patients who rely on daily medication to manage high blood pressure — one of the most common chronic health conditions worldwide.

Here’s what you need to know in simple terms.

---

💊 What Happened?

According to health regulators, more than 580,000 to nearly 600,000 bottles of a blood pressure medicine called prazosin hydrochloride were voluntarily recalled by the manufacturer.

The affected medication was found to potentially contain nitrosamine impurities, a type of chemical that can form during drug manufacturing or storage. These substances are known to be potentially carcinogenic (cancer-causing) when exposure is long-term or at high levels.

---

⚠️ Why Is This Dangerous?

Nitrosamines are not new in pharmaceutical safety alerts. They have previously been detected in several medications globally.

Health experts explain:

• Small exposure is generally not immediately harmful
• Long-term high exposure may increase cancer risk
• The risk depends on dosage and duration

Because of this, regulators classify this type of recall as a “Class II risk”, meaning:

👉 The product may cause temporary or reversible health effects
👉 Serious harm is considered unlikely but not impossible

---

🏭 Which Drug Is Affected?

The recall involves prazosin hydrochloride, a medication commonly used to:

• Treat high blood pressure (hypertension)
• Sometimes help with PTSD-related nightmares and sleep issues

It is widely prescribed and considered an important medication for many patients managing cardiovascular health.

---

🧪 What Exactly Was Found?

Testing revealed the presence of a specific impurity linked to nitrosamines — chemicals that can sometimes form during pharmaceutical production.

These impurities can appear when:

• Manufacturing processes change
• Raw materials react under certain conditions
• Storage conditions are not optimal

Experts say this issue has been seen before in other blood pressure drugs, leading to global recalls in recent years.